Balloon catheter used to prevent re-stenosis after angioplasty a

Details Balloon catheter used to prevent re-stenosis after angioplasty a Balloon catheter used to prevent re-stenosis after angioplasty a

1997-07-18

1999-09-07

Dvorak, Linda C.M.

Surgery

Radioactive substance applied to body for therapy

Radioactive substance placed within body

604 96, A61N 500

Patent

active

059478896

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

The invention concerns a balloon catheter.
Angioplasty of a narrowing in a vessel or a vessel stenosis caused by arteriosclerosis using a balloon catheter leads to excessive multiplication of cells in the walls of the vessel in 30 to 50% of all treated patients which contributes to a restenosis of the vessel. The angioplasty triggers excessive cell production in the tissue of the cell wall as well as migration of smooth muscle cells of the tissue into the innermost layer of the artery. This process leads to so-called intimal hyperplasia which once more narrows the vessel.
There are other usable angioplasty methods for opening closed vessels via a laser or with atherectomy catheters for removing the stenostic material. These methods, as is the case with the balloon catheter, lead however to intimal hyperplasia.
The use of radioactive radiation to prevent excessive cell growth is known in the art for treatment of tumors or of intimal hyperplasia.
One possibility is to utilize radioactive radiation for the prevention of intimal hyperplasia through the temporary introduction of radioactive instruments or apparatus into the arteries or into a balloon catheter (U.S. Pat. No. 5,199,939 or U.S. Pat. No. 5,213,561). These methods have the disadvantage that the walls of the vessel are not evenly irradiated (U.S. Pat. No. 5,199,939) due to a poor centering of a thin radioactive wire or catheter or that there is no direct contact between the radioactive element and the walls of the vessel (U.S. Pat. No. 5,213,561 and EP 0 633 041 A1) so that large radiation doses are necessary to prevent the restenosis.
Pure beta-emitters are e.g. mainly effective at short ranges in the tissue and the effect of the radiation decreases significantly with increasing distance from the source location. High energy gamma-radiation emitted e.g. from the radioactive nuclide Iridium-192 (U.S. Pat. No. 5,213,561)) penetrates the radioactive element guiding catheter without large dose losses. However, the radiation dose is not completely absorbed in the walls of the artery, rather penetrates into the body of the patient. All catheters having radioactive elements must be sufficiently flexible and soft in consistency in order to avoid injuring the vessels.
One possibility of directly irradiating the walls of the vessel with low doses is the utilization of radioactive stents or vessel implants (EP patent 04 33 011 A1 and DE patent 43 15 002 C1). The implantation of stents can, however, lead to blood clots and to the sealing of the vessels due to the introduction of foreign materials into the human arteries which could result in destruction of tissue in the organ being treated. In addition, conventional clinically used stents can cause foreign allergic reactions resulting in the diffusion of infective cells into the walls of the vessel. In addition, for purposes of minimizing the radioactive dose on the entire organism, a rapid short-term radiative treatment is preferred rather than a long-term radiation treatment using a radioactive vessel implant.
The invention avoids the above-mentioned disadvantages. The invention concerns a balloon catheter, a method for its production and a partially manufactured product (balloon catheter having metallic coating) which can be transformed into a balloon catheter in accordance with the invention through radioactive transformation.


SUMMARY OF THE INVENTION

Radioactive elements should be localized on the surface of balloon catheter and be sufficiently plastically deformable to remain in direct contact with the walls of the vessel in the event of irregularities in the vessel walls (generally the case for arteriosclerosis in people). An important feature of the invention is the direct and even irradiation of the walls of the artery due to the flexibility of a balloon made from plastic combined with a homogeneous distribution of the radioactivity on or in the surface. This is guaranteed with the use of radioactive nuclides which are anchored in the walls of the balloon or introduced i

REFERENCES:
patent: 5059166 (1991-10-01), Fischell et al.
patent: 5302168 (1994-04-01), Hess
patent: 5411466 (1995-05-01), Hess
patent: 5499980 (1996-03-01), Euteneuer
patent: 5782742 (1998-07-01), Crocker et al.

Affiliated with

Also associated with

Rating

Balloon catheter used to prevent re-stenosis after angioplasty a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Balloon catheter used to prevent re-stenosis after angioplasty a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Balloon catheter used to prevent re-stenosis after angioplasty a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1798343